entertainment -WSS

entertainment

author：entertainment 2025-08-12 11:28:15 - browse：9157

Dozens of sickle cells in a whirlpool — coverage from STAT — Adobe

Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes.

The document was supposed to help Novak, then the chief executive of CRISPR Therapeutics, navigate a pressing quandary. His company, along with two others, were founded to commercialize the new revolutionary gene-editing tool CRISPR-Cas9, which promised to cure numerous genetic diseases. But which should they target first? What was the best proof-of-concept?

“We looked at anything and everything,” said Novak, who stepped down as CEO in 2017 but remained on the board until this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Washington mulls new rules to avert another Change Healthcare

WSS

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Oprah kicked off a national conversation on obesity. Let's have it

Food as medicine: Medically tailored meals may get standardized

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

FDA investigates CAR

What to do when lifesaving products contribute to climate change

hotspot

entertainment

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

Supreme Court mifepristone arguments center on docs' right to sue

New air purifier tech could be key to improving indoor air quality

Food as medicine: Medically tailored meals may get standardized

In Memoriam: Notable people who died in 2023

Study says nonprofit hospitals fall short in charity care spending

Guidelines to prevent youth baseball injuries need more muscle

The EPA's new lead rule: How one expert crunched the numbers

Jerome Adams on the need for new antivirals for Covid

Flagship Pioneering launches a new biotech in two countries

hotspot

Scientists boost immune system in aging mice by making it youthful

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Supreme Court mifepristone arguments center on docs' right to sue

There's no autism epidemic. It's an autism diagnosis epidemic

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

UnitedHealth’s Optum accused of antitrust violations in California

focus

leisure time

leisure time

hotspot